NHSE funded test referrals should be in accordance with the National Genomic Test Directory for rare disease and meet eligibility criteria: National Genomic Test Directory - NHS England.
- R127 Long QT syndrome (LQTS)
Genetic testing for Long QT syndrome (LQTS) (R127) - R128 Brugada syndrome and cardiac sodium channel disease
Genetic testing for Brugada syndrome (R128) - R129 Catecholaminergic polymorphic VT (CPVT)
Genetic testing for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (R129) - R130 Short QT syndrome (SQTS)
Genetic testing for Short QT syndrome (SQTS) (R130) - R131 Hypertrophic cardiomyopathy (HCM)
Genetic testing for hypertrophic cardiomyopathy (HCM) (R131) - R132 Dilated and arrhythmogenic cardiomyopathy (DCM)
Genetic testing for dilated and arrhythmogenic cardiomyopathy (DCM) (R132) - R133 Arrhythmogenic cardiomyopathy
Genetic testing for arrhythmogenic cardiomyopathy (R133) - R134 Familial hypercholesterolemia
Genetic testing for familial hypercholesterolaemia (R134) - R135 Paediatric or syndromic cardiomyopathy
Genetic testing for paediatric cardiomyopathy (PaedCM) (R135) - R138 Molecular autopsy following sudden unexplained death
Genetic testing for cardiac arrhythmia of unknown type (Molecular Autopsy) (R138) - R328 Progressive cardiac conduction disease
Genetic testing for progressive cardiac conduction disease (PCCD)(R328)
Testing for previously identified familial variants, as clinically appropriate, is available.
Contact us
Oxford Genetics Laboratories - Contact us
Specific enquiries
Email: cardiac.oxfordgenetics@ouh.nhs.uk
Research
The laboratory is closely involved with the Watkins Research Group: Inherited Heart muscle Disease Group.
Further information on the cardiac genetics research undertaken by this group is available on the Radcliffe Department of Medicine Medical Sciences Division website.
